Table 2.
Age-standardized incidence rate of CV/heart diseases in secondary prevention
| Group | ASIR of CV/heart disease in 1999 | Summary | Trend 1 | Trend2 | ||
|---|---|---|---|---|---|---|
| AAPC | Years | APC | Years | APC | ||
| Total | 51.7‰ | −3.9 [− 7.4; −0.4]* | 1999–2001 | −13.7 [− 34.4; 13.5] | 2001–2013 | −2.2 [− 3.8; − 0.6]* |
| Women | 50.3‰ | −2.8 [− 4.5; − 1.1]* | 1999–2013 | −2.8 [− 4.5; − 1.1]* | ||
| 50–59 | 34.5‰ | −1.2 [− 6.5; 4.4] | 1999–2013a | −1.2 [− 6.5; 4.4] | ||
| 60–69 | 33.2‰ | − 0.7 [− 3.8; 2.5] | 1999–2013 | − 0.7 [− 3.8; 2.5] | ||
| 70–79 | 50.5‰ | −3.3 [− 6.7; 0.1] | 1999–2013 | −3.3 [− 6.7; 0.1] | ||
| 80+ | 66.6‰ | −3.7 [−5.4; − 2.1]* | 1999–2013 | −3.7 [− 5.4; − 2.1]* | ||
| Men | 52.8‰ | −3.3 [− 5.1; − 1.5]* | 1999–2013 | −3.3 [− 5.1; − 1.5]* | ||
| 50–59 | 33.5‰ | −1.1 [− 4.9; 2.9] | 1999–2013 | − 1.1 [− 4.9; 2.9] | ||
| 60–69 | 51.4‰ | − 3.3 [− 5.4; − 1.1]* | 1999–2013 | − 3.3 [− 5.4; − 1.1]* | ||
| 70–79 | 58.0‰ | −3.7 [− 6.3; − 1.1]* | 1999–2013 | −3.7 [− 6.3; − 1.1]* | ||
| 80+ | 64.1‰ | −3.2 [− 5.5; − 0.8]* | 1999–2013 | −3.2 [− 5.5; − 0.8]* | ||
*p < 0.05; awithout 2002 because it was 0, ASIR age-standardized incidence rate, AAPC average annual percentage change, APC annual percentage change